These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. 1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies. La Regina G; D'Auria FD; Tafi A; Piscitelli F; Olla S; Caporuscio F; Nencioni L; Cirilli R; La Torre F; De Melo NR; Kelly SL; Lamb DC; Artico M; Botta M; Palamara AT; Silvestri R J Med Chem; 2008 Jul; 51(13):3841-55. PubMed ID: 18529046 [TBL] [Abstract][Full Text] [Related]
9. Beta-methyl substitution of cyclohexylalanine in Dmt-Tic-Cha-Phe peptides results in highly potent delta opioid antagonists. Tóth G; Ioja E; Tömböly C; Ballet S; Tourwé D; Péter A; Martinek T; Chung NN; Schiller PW; Benyhe S; Borsodi A J Med Chem; 2007 Jan; 50(2):328-33. PubMed ID: 17228874 [TBL] [Abstract][Full Text] [Related]
10. Selective angiotensin II AT(2) receptor agonists devoid of the imidazole ring system. Murugaiah AM; Wallinder C; Mahalingam AK; Wu X; Wan Y; Plouffe B; Botros M; Karlén A; Hallberg M; Gallo-Payet N; Alterman M Bioorg Med Chem; 2007 Nov; 15(22):7166-83. PubMed ID: 17825570 [TBL] [Abstract][Full Text] [Related]
11. Discovery of substituted biphenyl imidazoles as potent, bioavailable bombesin receptor subtype-3 agonists. He S; Dobbelaar PH; Liu J; Jian T; Sebhat IK; Lin LS; Goodman A; Guo C; Guzzo PR; Hadden M; Henderson AJ; Ruenz M; Sargent BJ; Yet L; Kelly TM; Palyha O; Kan Y; Pan J; Chen H; Marsh DJ; Shearman LP; Strack AM; Metzger JM; Feighner SD; Tan C; Howard AD; Tamvakopoulos C; Peng Q; Guan XM; Reitman ML; Patchett AA; Wyvratt MJ; Nargund RP Bioorg Med Chem Lett; 2010 Mar; 20(6):1913-7. PubMed ID: 20167483 [TBL] [Abstract][Full Text] [Related]
12. N1-(3-cyclohexylbutanoyl)-N2-[3-(1H-imidazol-4-yl)propyl]guanidine (UR-AK57), a potent partial agonist for the human histamine H1- and H2-receptors. Xie SX; Kraus A; Ghorai P; Ye QZ; Elz S; Buschauer A; Seifert R J Pharmacol Exp Ther; 2006 Jun; 317(3):1262-8. PubMed ID: 16554355 [TBL] [Abstract][Full Text] [Related]
13. Phenyl ureas of creatinine as mGluR5 antagonists. A structure-activity relationship study of fenobam analogues. Wållberg A; Nilsson K; Osterlund K; Peterson A; Elg S; Raboisson P; Bauer U; Hammerland LG; Mattsson JP Bioorg Med Chem Lett; 2006 Mar; 16(5):1142-5. PubMed ID: 16380255 [TBL] [Abstract][Full Text] [Related]
14. Acylguanidines as bioisosteres of guanidines: NG-acylated imidazolylpropylguanidines, a new class of histamine H2 receptor agonists. Ghorai P; Kraus A; Keller M; Götte C; Igel P; Schneider E; Schnell D; Bernhardt G; Dove S; Zabel M; Elz S; Seifert R; Buschauer A J Med Chem; 2008 Nov; 51(22):7193-204. PubMed ID: 18950149 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of alkoxy-phenylamides and alkoxy-phenylimidazoles as potent sphingosine-1-phosphate receptor subtype-1 agonists. Evindar G; Bernier SG; Kavarana MJ; Doyle E; Lorusso J; Kelley MS; Halley K; Hutchings A; Wright AD; Saha AK; Hannig G; Morgan BA; Westlin WF Bioorg Med Chem Lett; 2009 Jan; 19(2):369-72. PubMed ID: 19081720 [TBL] [Abstract][Full Text] [Related]
16. Stereochemical diversity-oriented conformational restriction strategy. Development of potent histamine H3 and/or H4 receptor antagonists with an imidazolylcyclopropane structure. Watanabe M; Kazuta Y; Hayashi H; Yamada S; Matsuda A; Shuto S J Med Chem; 2006 Sep; 49(18):5587-96. PubMed ID: 16942032 [TBL] [Abstract][Full Text] [Related]
17. IRAK-4 inhibitors. Part II: a structure-based assessment of imidazo[1,2-a]pyridine binding. Buckley GM; Ceska TA; Fraser JL; Gowers L; Groom CR; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V Bioorg Med Chem Lett; 2008 Jun; 18(11):3291-5. PubMed ID: 18482836 [TBL] [Abstract][Full Text] [Related]
18. Nascent structure-activity relationship study of a diastereomeric series of kappa opioid receptor antagonists derived from CJ-15,208. Dolle RE; Michaut M; Martinez-Teipel B; Seida PR; Ajello CW; Muller AL; DeHaven RN; Carroll PJ Bioorg Med Chem Lett; 2009 Jul; 19(13):3647-50. PubMed ID: 19464172 [TBL] [Abstract][Full Text] [Related]
19. The search for novel TRPV1-antagonists: from carboxamides to benzimidazoles and indazolones. Fletcher SR; McIver E; Lewis S; Burkamp F; Leech C; Mason G; Boyce S; Morrison D; Richards G; Sutton K; Jones AB Bioorg Med Chem Lett; 2006 Jun; 16(11):2872-6. PubMed ID: 16563760 [TBL] [Abstract][Full Text] [Related]
20. Discovery of potent & selective inhibitors of activated thrombin-activatable fibrinolysis inhibitor for the treatment of thrombosis. Bunnage ME; Blagg J; Steele J; Owen DR; Allerton C; McElroy AB; Miller D; Ringer T; Butcher K; Beaumont K; Evans K; Gray AJ; Holland SJ; Feeder N; Moore RS; Brown DG J Med Chem; 2007 Nov; 50(24):6095-103. PubMed ID: 17990866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]